Check out our partners of
Healthy Funding IV

Happy to provide venture and growth capital for ambitious companies with at least one female founder/entrepreneur.

Are you:

• A female entrepreneur/founder with at least 5% shareholding?
• Established (with a head office) in the Netherlands?
• A company with a minimum turnover of around €500k?
• A company that contributes positively to reducing inequality? Also called Femtech or gendered innovation.
• A company with growth potential and strong ambitions?
• A company that values support from a diverse team?

Then we would like to discuss the possibilities with you during Healthy Funding IV. Can you answer only one or a few of the questions with yes? If so, we will be able to help you.

Borski Fund works from a network of experienced entrepreneurs. Main partners of the fund are StartGreen Capital and TheNextWomen. Investors in Borski Fund are the major banks of the Netherlands, reputable family offices, and more than 25 experienced entrepreneurs and investors who have founded, led and sold companies in tech, business services, PE, travel, medical technology, IT, textiles, HR, advertising and food industries, among others.   

Through active coaching of the 7 medtech entrepreneurs, the fund expects to accelerate development and commercialization timelines and rapidly increase the value of the companies invested in. The Blue Sparrows have encountered the medical market in real life; their mistakes are not to be made again and their hands-on, done-it-before experience paves the pathway to success. Harvard published research showing that such experience increases the chances of success of a company by 50%.

CbusineZ invests in new initiatives with a very specific reason: to help solve problems in healthcare and thus contribute to better care for patients and a sustainable system. They do this in the form of setting up new ventures (incubators) or by participating in ventures. In both cases, they actively and boldly support early stage ventures. Not as a quick fix, but for the long term; what matters to them is the impact they can realize. They expect from their ventures strong entrepreneurship, an A-team and of course a good business plan.

The InvestorsClub is a network of active investors. An active investor is an investor who shows interest in the other investors, in the entrepreneurs, attends our events as much as possible and is looking for an investment.

EIT Health brings together the Investor Network, an Europe-wide consortium of investors offering early-stage funding to promising healthcare start-ups. The EIT Health Investor Network facilitates early-stage fundraising across Europe to help accelerate innovative ideas to health markets faster. The network connects qualified companies seeking funding with a pool of selected European investors. They work with investors including early-stage venture capitalists, family offices, angel networks or super angels.

Erasmus MC, with financial support from RVO (Rijksdienst voor Ondernemend Nederland), has created ErasSupport, an investment tool specifically for early-stage companies and aspiring entrepreneurs who are from or in close collaboration with Erasmus MC. ErasSupport provides a maximum loan of €20,000 per project and access to a network of innovation-focused organizations in the Netherlands, particularly in the Rotterdam region. This will give entrepreneurs the chance to connect with existing entrepreneurs, hone their entrepreneurial skills and pick up valuable tips and tricks! The initial funding and networking will allow entrepreneurs to accelerate their venture’s growth and make it more attractive for future investors. Learn here more about the team and work process.

Holland Capital is one of the first independent private equity firms in the Netherlands. We have been investing responsibly and successfully in promising Dutch SMEs with growth ambitions for over 38 years. With a clear investment strategy we respond to long-term trends in attractive growth markets, focusing on Healthcare and Technology. Our experienced and committed investment team knows what business is and strives for an open, long-term and professional relationship with the management teams, with the common goal of achieving optimal growth. From a dedicated healthcare team, we support innovations in the field of digital health and med tech, both financially and strategically/operationally. For example, we have previously invested in Karify (ehealth provider, sold Avinty in 2020), Quantib (AI radiology) and LivAssured (Epilepsy detection), among others.

Health Innovations invests in young companies that make healthcare better and more affordable. They focus on innovative care concepts, eHealth, medical technology, Digital Health and Health Services. The working method focuses on the market: How can companies contribute to improving healthcare processes? They invest in the Seed and Growth phase and the investment must contribute to value creation for healthcare, the entrepreneurs and the shareholders. They play an active role as shareholder by contributing their knowledge, experience and network, but do not take the place of the entrepreneur. The partnerships usually last 3 to 8 years. Have you developed a product or service that will improve healthcare and are you looking for funding for your business? Health Innovations invests in young innovative startups in healthcare.

For more than 25 years, Hezelburcht has used subsidies to achieve its clients’ strategic and financial objectives. Their knowledge of the subsidy schemes and their content, network and knowledge of the sectors in which they operate enable them to prepare applications with the greatest chance of success.

The Holland United States Bridge program is focused on providing Dutch Life Sciences companies with successful access to the United States capital & healthcare market. The HUB program is an intense, highly customized one-year program. The most promising Dutch life science companies are matched with experienced industry leaders to receive high-level strategic advice and provide hands-on support. 

Investment Partners (HIP for short) aims to invest in promising innovative companies in healthcare that make an impact in terms of prevention, efficiency and/or quality. HIP selects the companies based on their ability to make a sustainable impact and generate healthy returns. HIP supports the companies with financial resources and hands-on guidance. In this way, HIP aims to take promising companies to the next stage and offer its investors an attractive return.

Kaasstad Kapitaal offers entrepreneurs the opportunity to present their business plans to a group of informal investors. They focus on entrepreneurs with a capital requirement of € 50,000 to € 2.5 million.

Investment strategy Health-IT and MedTech

The healthcare sector is under pressure and healthcare costs continue to rise. NextGen Ventures’ investment strategy focuses on applications where data can provide added value, such as remote care or artificial intelligence. In addition, the fund is interested in specific treatments that make care more efficient and effective, such as new minimally invasive treatments. NextGen Ventures prefers to focus on companies with scalable innovations that have moved beyond the idea phase and are working towards a market position. Among others, health insurer Menzis, De Friesland Zorgverzekeraar, Stichting Triade (affiliated with the University Medical Center Groningen) and Noaber Foundation have invested in the fund from the consideration that they are making a positive contribution to health and healthcare.

Are you an entrepreneur with a good innovative idea and looking for a loan to start up your company? With a Rabo Innovation Loan you can start developing your plans in time. Rabobank is happy to help finance innovations. Especially when there are no proven results, cash flow or paying customers. Are you working on developments that contribute to digitization or a more sustainable society? Or is your company focused on developments in the field of vitality? Then request the brochure from Rabobank and share your plan.

SubsidyCloud is the first and only data driven grant management platform used by innovative companies and foundations to continuously discover potential grants and connect with grant consultants, industry experts and (international) consortia. This is done through an innovative matching engine that gives you an overview of all grants available for your company and projects.

Symbid makes venture capital accessible for ambitious entrepreneurs. At Symbid, ambitious entrepreneurs present their plans to tens of thousands of crowdfunders and professional investors. These crowdfunders invest in the company they believe in and become shareholders. This way they benefit from the future growth of the company.

Swanbridge Capital is a Rotterdam based venture capital fund that actively invests in young, high potential companies in the life sciences. They focus on companies that are in very early stage in their development of therapeutics, diagnostics and medical devices.

UNIIQ is a €22m investment fund focused on the proof-of-concept phase. UNIIQ helps entrepreneurs in South Holland to bring their unique innovation to the market faster. They offer entrepreneurs the seed capital to realize their plans and bridge the most risky phase from concept to promising company.

The mission of the VanPaz is to contribute to the advancement of ICT with societal impact especially for frail people: the elderly, children with special needs, and chronic patients. It aims to bridge the gap between cutting-edge R&D and market by mentoring promising researchers on the business aspects of their work as well as searching for funding sources for their businesses. 

4impact.vc believes that companies focusing on societal, sustainable and financial return will outperform and the global tech revolution will continue to expand rapidly. They focus on technology-driven companies in three investment areas: inclusion, health & well-being, environment.